Profitelligence Profitelligence · Filing Ledger Search all insiders →

Insider Profile · SEC Form 4 Activity · Trailing 90 Days

Lippis Daniel J.

Over the trailing 90 days, Lippis Daniel J. (Other Officer at Edwards Lifesciences Corp) traded $426K of stock (net selling $156K) in EW, per 16 SEC Form 4 transactions.

Role
Other Officer
Companies
EW
Window
Trailing 90 days · 16 transactions · CIK 2004380
Net activity
−$156K ($135K bought · $291K sold)

By Company (Trailing 90 Days)

SymbolCompanyTxnsBoughtSoldNet
EWEdwards Lifesciences Corp16$135K$291K−$156K

Transactions (16)

DateSymbolTypeSharesValueDescription
2026-07-10EWSell619$57KOpen market or private sale
2026-07-10EWSell619$0Exercise or conversion of derivative security
2026-07-10EWBuy619$45KExercise or conversion of derivative security
2026-07-07EWSell377$36KPayment of exercise price or tax liability by delivering securities
2026-06-30EWSell619$57KOpen market or private sale
2026-06-30EWBuy619$45KExercise or conversion of derivative security
2026-06-30EWSell619$0Exercise or conversion of derivative security
2026-05-18EWSell620$0Exercise or conversion of derivative security
2026-05-18EWSell620$50KOpen market or private sale
2026-05-18EWBuy620$45KExercise or conversion of derivative security
2026-05-11EWSell362$29KPayment of exercise price or tax liability by delivering securities
2026-05-08EWSell450$37KPayment of exercise price or tax liability by delivering securities
2026-05-07EWBuy7.8K$0Grant, award or other acquisition
2026-05-07EWSell309$26KPayment of exercise price or tax liability by delivering securities
2026-05-07EWBuy39.9K$0Grant, award or other acquisition
2026-05-07EWBuy7.8K$0Grant, award or other acquisition

Activity shown covers the trailing 90 days of SEC Form 4 filings. "Buy" and "sell" follow the SEC acquired/disposed codes and include compensation events (grants, option exercises, tax withholding) unless noted. Historical fact, not investment advice.

Follow Lippis

Real-time Form 4 alerts, insider track records, and cluster detection — matched to your watchlist.

Start free